Scientific Publications

 

Dr. Levy's work is documented in numerous peer-reviewed journal articles and issued/published patents.

Additionally, he has presented his work in various scientific forums.

Dr. Levy is both author and editor of several books covering sugar chemistry and organic reaction mechanisms.

 

- Papers

- Patents

- Presentations/Posters

 

Oral Presentations

 

From Full Time Employment to Consulting – Strategies for Successful Transition.  Daniel E. Levy.  Symposium on Entrepreneurship in Chemistry: True Stories of Entrepreneurs; Abstract 359, Division of Small Chemical Business, 44th ACS Western Regional Meeting – Santa Clara, CA, October 5, 2013.  Invited Presentation.

 

Medicinal Chemistry Strategies Targeting Cardiac Function.  Daniel E. Levy.

 

         - General Topics in Early Pharma Development (Biology 202TB).  Professional Science Master of Biotechnology Program at San Jose State

           University.  February 11, 2014.  Invited Guest Lecturer.

         - Colloquium in Microbiology, Cell and Molecular Biology (BIOL 871).  San Francisco State University.  May 2, 2013.  Invited Guest Lecturer.

         - General Topics in Early Pharma Development (Biology 202TB).  Professional Science Master of Biotechnology Program at San Jose State

           University.  February 26, 2013.  Invited Guest Lecturer.

         - Special Topics in Clinical Trials Management I (SMPD 289A).  Medical Product Development Management Program at San Jose State University.

           November 12, 2012.  Invited Guest Lecturer.

 

Chemistry Outsourcing: Avoiding Problems and Maximizing Benefits.  Daniel E. Levy.

 

         - Strategies for Success in Virtual Drug Development and Discovery – Business Development Connections.  April 15, 2013.  Invited Presentation.

         - Strategies for Success in Virtual Drug Development from Discovery to Clinic – Business Development Connections.  November 1, 2012.  Invited

           Presentation.

 

Assessing the Development Potential of Early Stage Compounds.  Tom Crawford, William Leong, Daniel Levy, Maxwell M. Reeve.  Pharma ChemOutsourcing 2012 – Panel discussion, Day 4.  September 13, 2012.  Invited Panelist and Moderator.

 

Early API Development, Contractors, Consultants & Other Adventures. Narinjam M. Deo, Kenneth N. Drew, Mark A Krook, Hamilton Lenox, Sonia Pawlak, Daniel E. Levy.  Pharma Chem Outsourcing 2012 - Opening plenary panel discussion, Day 1.  September 10, 2012. Invited Panelist.

 

Creating Opportunities in the Life Sciences: Maintaining Self Employment in a Difficult Job Climate.  Daniel E. Levy.  August 28, 2012.  Bio2Device Group - Sunnyvale, CA.  Invited Presentation.

 

Chemistry Careers and the Current Economy: Strategies for Survival and Adaptability.  Daniel E. Levy; Symposium on Chemistry at the Interfaces: Careers in Chemistry Outside the Lab; Abstract 7, Division of Business Development and Management, 243rd ACS National Meeting – San Diego, March 27, 2012.

 

Creating Opportunities: Generating Consulting Income in a Hostile Market.  Daniel E. Levy.  November 17, 2011.  Bay Area Biomedical Consultants Network (BABCN) – Millbrae, CA.  Invited Presentation.

 

Nanoparticle-Based Delivery of siRNA.  Daniel E. Levy; Brian Frederick; Zhongli Ding; Bing Luo; Samuel Zalipsky; Symposium on Nanoscaled Materials for Drug Delivery and Diagnostic Applications; Abstract 856, Division of Organic Chemistry, 240th ACS National Meeting - Boston, August 25, 2010.  Invited Presentation.

 

RNAi Nanoplex Technology - Intradigm's Promise to Medicine.  Daniel E. Levy.  September 8, 2009.  Bio2Device Group - Palo Alto, CA.  Invited Presentation.

 

Pharmacological Inhibition of Cardiac Adenylyl Cyclase in an Isoform-Specific Manner. Kousaku Iwatsubo; Susumu Minamisawa; Yoshiyuki Toya; Robert M. Scarborough; Diana B. Cherbavaz; Ming Bao; James E. Tomlinson; David M. Sedlock; Satoshi Umemura; Daniel E. Levy; Charles J. Homcy; Yoshihiro Ishikawa; American Heart Association Scientific Sessions 2002.  Chicago, IL.  November 18, 2002.

 

The Organic Chemistry of Sugars. January 4, 1999.  Stanford University seminar class on "Special Topics in Organic Chemistry."  Invited Presentation.

 

Matrix Metalloproteinase Inhibitors:  Novel Therapeutics for Cancer and Inflammation.  CHI symposium on "Protease Inhibitors - New Therapies and Approaches."  November 6-7, 1996.  Baltimore, MD.  Invited Speaker and Chair of Session on "Matrix Metalloproteinases for Cancer and Inflammation".

 

Matrix Metalloproteinase Inhibitors. March 1, 1996.  Departmental Seminar.  University of Kentucky - Lexington, KY.  Invited Presentation.

 

 

Posters

 

Inhibition of Calmodulin-dependent Kinase IIδ. Jeffrey N. Higaki; Yong-jin Xu; Indrani Chakraborty; Hanmin Dong; Michael Lasecki; Maureen Laney; Daniel E. Levy; Qing Lu; Babu Mavunkel; Sundeep Dugar; Linda S. Higgins; Johnson & Johnson Structural Biology Symposium.  July 25, 2005.

 

Metal Coordination Based Inhibitors of Adenylyl Cyclase:  The Effect of Acyclic Linkers on P-Site Binding.  Daniel E. Levy; Charles Marlowe; Kim Kane-Maguire; Ming Bao; Diana Cherbavaz; Jim Tomlinson; David Sedlock; Robert M. Scarborough;  Abstract 65, Division of Medicinal Chemistry, 223rd ACS National Meeting -- Orlando, April 7-11, 2002.

 

Metal Coordination Based Inhibitors of Adenylyl Cyclase:  The Effect of Cyclic Linkers on P-Site Binding.  Daniel E. Levy; Ming Bao; Jim Tomlinson; Robert M. Scarborough;  Abstract 66, Division of Medicinal Chemistry, 223rd ACS National Meeting -- Orlando, April 7-11, 2002.

 

Matrix Metalloprotease Inhibition Reduces Collagen Synthesis and Content After Arterial Injury.  Shamir R. Mehta; Robert Chisholm; Ranga Robinson; Richard Logan; Daniel E. Levy; Alan M. Ezrin; Fred W. Keeley; Bradley H. Strauss;  45th Annual Scientific Session, American College of Cardiology -- Orlando, March 1996.

 

Matrix Metalloprotease Inhibition Reduces Collagen Synthesis and Content After Arterial Injury. Shamir R. Mehta; Robert Chisholm; Ranga Robinson; Richard Logan; Daniel E. Levy; Alan M. Ezrin; Fred W. Keeley; Bradley H. Strauss;  68th Scientific Sessions, American Heart Association -- Anaheim, November 13-16, 1995.

 

Metalloproteinase Inhibitors Prevent Neointimal Proliferation in an In Vitro Model of Restenosis. Peter Zahradka; Daniel E. Levy; David P. Wilson;  International Society for Heart Research 16th Meeting of the European Section -- Prague, July 2-7, 1995.

 

Complex Carbohydrate Mimetic:  Design and Synthesis of Novel Mimetic of Sialyl Lewis Epitope.  Cho Tang; Dan Levy; Asaad Nematalla; Mina Nashed; Saeed Abbas; Paper 009, Division of Medicinal Chemistry, 209th ACS National Meeting -- Anaheim, April 2-6, 1995.

 

A Hydroxamic Acid Matrix Metalloprotease Inhibitor Blocks the Activity of Endothelin Converting Enzyme in Anesthetized Rats. Daniel E. Levy; Peng Cho Tang; Keri Sweet; Brent Summers; France LaPierre; Alan M. Ezrin; Abstract 159, Division of Medicinal Chemistry, 209th ACS National Meeting -- Anaheim, April 2-6, 1995.

 

C-Glycopeptides as Potential Inhibitors of Cell Adhesion Molecules.  Daniel E. Levy; Peng Cho Tang; Kevin Holme; Brian K. Brandley; Kim Bradbury; Carrol Foxall; Yuko Oda; Narasinga Rao; Abstract 120, Division of Medicinal Chemistry, 208th ACS National Meeting -- Washington DC, August 21-25, 1994.

 

- Books